- Home
- RYTM vs ESAB Comparison
RYTM vs ESAB Comparison
Compare RYTM & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RYTM | ESAB |
|---|---|---|
| Founded | 2008 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.4B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | RYTM | ESAB |
|---|---|---|
| Price | $102.96 | $118.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | $129.92 | ★ $141.00 |
| AVG Volume (30 Days) | ★ 616.7K | 308.4K |
| Earning Date | 02-25-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.95 |
| Revenue | $174,334,000.00 | ★ $2,792,325,000.00 |
| Revenue This Year | $47.78 | $3.22 |
| Revenue Next Year | $56.52 | $7.78 |
| P/E Ratio | ★ N/A | $29.78 |
| Revenue Growth | ★ 54.92 | 1.19 |
| 52 Week Low | $45.91 | $100.17 |
| 52 Week High | $122.20 | $135.84 |
Technical Indicators
Market Signals| Indicator | RYTM | ESAB |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 52.57 |
| Support Level | $101.47 | $119.04 |
| Resistance Level | $109.02 | $125.03 |
| Average True Range (ATR) | 5.38 | 3.31 |
| MACD | -0.02 | -0.24 |
| Stochastic Oscillator | 42.64 | 48.78 |
Price Performance
Historical ComparisonAbout RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.